Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarantelli

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Science Advances|December 25, 2015
Climate change and glacier retreat drive shifts in an Antarctic benthic ecosystemRicardo Sahade, Cristian Lagger, Luciana Torre, et al.
Cancers|June 26, 2025
KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell LymphomasChiara Tarantelli, Filippo Spriano, Elisa Civanelli, et al.
Haematologica|January 26, 2019
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agentsChiara Tarantelli, Lu Zhang, Elisabetta Curti, et al.
Physical Review Letters|February 2, 2013
Multiphoton ionization as a clock to reveal molecular dynamics with intense short x-ray free electron laser pulsesL Fang, T Osipov, B Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomasE Gaudio, C Tarantelli, I Kwee, et al.
British Journal of Haematology|July 30, 2019
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomasFilippo Spriano, Chiara Tarantelli, Eugenio Gaudio, et al.
The Journal of Chemical Physics|December 24, 2008
Double photoionization of thiophene and bromine-substituted thiophenesP Linusson, L Storchi, F Heijkenskjöld, et al.
The Western Journal of Emergency Medicine|March 18, 2022
Impact of COVID-19 on Emergency Medicine Residency Programs: A Cross-Sectional Study in New York StateMuhammad Waseem, Nidhi Garg, Bernard P Chang, et al.
British Journal of Haematology|December 9, 2022
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103Filippo Spriano, Chiara Tarantelli, Alberto J Arribas, et al.
British Journal of Haematology|July 31, 2024
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agentsFilippo Spriano, Chiara Tarantelli, Luciano Cascione, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Science Advances|December 25, 2015
Climate change and glacier retreat drive shifts in an Antarctic benthic ecosystemRicardo Sahade, Cristian Lagger, Luciana Torre, et al.
Cancers|June 26, 2025
KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell LymphomasChiara Tarantelli, Filippo Spriano, Elisa Civanelli, et al.
Haematologica|January 26, 2019
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agentsChiara Tarantelli, Lu Zhang, Elisabetta Curti, et al.
Physical Review Letters|February 2, 2013
Multiphoton ionization as a clock to reveal molecular dynamics with intense short x-ray free electron laser pulsesL Fang, T Osipov, B Murphy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomasE Gaudio, C Tarantelli, I Kwee, et al.
British Journal of Haematology|July 30, 2019
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomasFilippo Spriano, Chiara Tarantelli, Eugenio Gaudio, et al.
The Journal of Chemical Physics|December 24, 2008
Double photoionization of thiophene and bromine-substituted thiophenesP Linusson, L Storchi, F Heijkenskjöld, et al.
The Western Journal of Emergency Medicine|March 18, 2022
Impact of COVID-19 on Emergency Medicine Residency Programs: A Cross-Sectional Study in New York StateMuhammad Waseem, Nidhi Garg, Bernard P Chang, et al.
British Journal of Haematology|December 9, 2022
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103Filippo Spriano, Chiara Tarantelli, Alberto J Arribas, et al.
British Journal of Haematology|July 31, 2024
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agentsFilippo Spriano, Chiara Tarantelli, Luciano Cascione, et al.
Pageof 18